BioImpact

BioImpact

Signal active

Investment Firm

Overview

BioImpact supports the collection of information such as statistical data, and more effective information transmission centered on “research”.

The company is a web production company whose business domain is the research industry. Researchers' results reports are published nationwide on a daily basis, but the impact is difficult to convey to the world and is difficult to reach. BioImpact provides a variety of services to connect companies, researchers, centering on the four businesses of media, production, sales or sales support, and database”.

Highlights

Founded

2006

Industry

Information Services

Employees

11-50

Investment

2

Lead Investment

0

Exits

undefined

Stages

Early Stage Venture, Seed

Investor Type

N/A

Location

Asia

Contact Information

Social

Profile Resume

BioImpact, established in 2006 and headquartered in Asia., specializes in Early Stage Venture, Seed investments across Biotechnology, Pharmaceutical, Medical, Therapeutics, Venture Capital, Life Science, Health Care, Oncology, Manufacturing, Information Technology. Their recent investments include Orna Therapeutics, MPM Capital, Merck, Inner Resource, DNX Ventures. The highest investment round they participated in was $16.8B. Among their most notable exits are Orna Therapeutics and MPM Capital. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Junichi Sugihara

Junichi Sugihara

President and CEO

Investment portfolio

BioImpact has made 2 investments. Their most recent investment was on Feb 13, 2019, when Inner Resource raised $721.2K.

BioImpact has made 1 diversity investments. Their most recent diversity investment was on Aug 16, 2022, when Orna Therapeutics raised $221.0M.

investments

2

Diversity investments

1

Lead investments

0

Number of exits

undefined

Investments

2

Annouced DateOrganization NameIndustryMoney Raised
Feb 13, 2019
Inner Resource Inner Resource
Information Technology721.2K
Aug 16, 2022
Orna Therapeutics Orna Therapeutics
Biotechnology221.0M

Exits

0

Funding Timeline

Funding rounds

2

Investors

0

Funds

0

Funding Rounds

2

BioImpact has raised 2 rounds. Their latest funding was raised on Aug 16, 2022 from a Series B - Orna Therapeutics round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Feb 13, 2019
Seed Round - Inner Resource Seed Round - Inner Resource
-721.2K-
Aug 16, 2022
Series B - Orna Therapeutics Series B - Orna Therapeutics
-221.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.